Truist Securities Reiterates Buy Rating on AxoGen, Inc. (AXGN)

September 29, 2026 5:06 AM

Truist Securities analyst Ravi Misra reiterated a Buy rating and $60.00 price target on AxoGen, Inc. (NASDAQ: AXGN).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found